Viewing Study NCT05892757


Ignite Creation Date: 2025-12-24 @ 7:07 PM
Ignite Modification Date: 2025-12-25 @ 4:41 PM
Study NCT ID: NCT05892757
Status: COMPLETED
Last Update Posted: 2024-03-12
First Post: 2023-05-30
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Study to Assess Adverse Events and Compare How Oral Ubrogepant and Oral Atogepant Moves Through the Body of Healthy Female Adult Volunteers
Sponsor: AbbVie
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module